#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA621000	Functional	Antitumor activity in vivo against the 6C3HED lymphosarcoma dosed for 10 days at 200 mg/kg	Mus musculus	1	ALA1124898	organism-based format	Scientific Literature
2.	ALA619829	Functional	Tested on 6C3HED lymphosarcoma and percent inhibition was determined at 100 mg/kg dosage administered for 8 days intraperitoneally	Mus musculus	1	ALA1124898	organism-based format	Scientific Literature
3.	ALA619830	Functional	Tested on 6C3HED lymphosarcoma and percent inhibition was determined at 200 mg/kg dosage administered for 10 days intraperitoneally	Mus musculus	1	ALA1124898	organism-based format	Scientific Literature
4.	ALA619831	Functional	Tested on 6C3HED lymphosarcoma and percent inhibition was determined at 200 mg/kg dosage administered for 8 days intraperitoneally	Mus musculus	1	ALA1124898	organism-based format	Scientific Literature
5.	ALA619832	Functional	Tested on 6C3HED lymphosarcoma and percent inhibition was determined at 50 mg/kg dosage administered for 8 days intraperitoneally	Mus musculus	1	ALA1124898	organism-based format	Scientific Literature
6.	ALA619833	ADME	Tested on 6 C3 HED lymphosarcoma and number of drug related deaths/total animals in treatment group was determined at 100 mg/kg dosage administered for 8 days intraperitoneally; 0/10	Mus musculus	1	ALA1124898	organism-based format	Scientific Literature
7.	ALA619834	ADME	Tested on 6 C3 HED lymphosarcoma and number of drug related deaths/total animals in treatment group was determined at 200 mg/kg dosage administered for 8 days perorally; 1/10	Mus musculus	1	ALA1124898	organism-based format	Scientific Literature
8.	ALA619835	ADME	Tested on 6 C3 HED lymphosarcoma and number of drug related deaths/total animals in treatment group was determined at 200 mg/kg dosage administered for 10 days intraperitoneally; 1/10	Mus musculus	1	ALA1124898	organism-based format	Scientific Literature
9.	ALA619836	ADME	Tested on 6 C3 HED lymphosarcoma and number of drug related deaths/total animals in treatment group was determined at 50 mg/kg dosage administered for 8 days perorally; 3/10	Mus musculus	1	ALA1124898	organism-based format	Scientific Literature
10.	ALA619840	Functional	Antitumor activity in vivo expressed as percent of inhibition in 6C3HED-lymphosarcoma tumor cell line	Mus musculus	2	ALA1124898	organism-based format	Scientific Literature
11.	ALA643808	Functional	Antitumor activity in vivo and the activity was determined as percent increase in life span determined against B-16-melanoma (ascites) cell lines	Mus musculus	2	ALA1124898	organism-based format	Scientific Literature
12.	ALA643809	Functional	Antitumor activity in vivo expressed as percent of inhibition in B-16-melanoma (solid) cell line	Mus musculus	1	ALA1124898	organism-based format	Scientific Literature
13.	ALA651022	Functional	Tested on CA-755 mammary adenocarcinoma and percent inhibition was determined at 100 mg/kg dosage administered for 10 days intraperitoneally.	Mus musculus	1	ALA1124898	organism-based format	Scientific Literature
14.	ALA651023	Functional	Tested on CA-755 mammary adenocarcinoma and percent inhibition was determined at 150 mg/kg dosage administered for 10 days intraperitoneally.	Mus musculus	1	ALA1124898	organism-based format	Scientific Literature
15.	ALA651024	Functional	Tested on CA-755 mammary adenocarcinoma and percent inhibition was determined at 50 mg/kg dosage administered for 10 days intraperitoneally.	Mus musculus	1	ALA1124898	organism-based format	Scientific Literature
16.	ALA651025	ADME	Tested on CA-755 mammary adenocarcinoma and Number of drug related deaths/total animals in treatment group was determined at 50 mg/kg dosage administered for 10 days intraperitoneally; 2/10	Mus musculus	1	ALA1124898	organism-based format	Scientific Literature
17.	ALA875697	ADME	Tested on CA-755 mammary adenocarcinoma and number of drug related deaths/total animals in treatment group was determined at 100 mg/kg dosage administered for 10 days intraperitoneally; 1/7	Mus musculus	1	ALA1124898	organism-based format	Scientific Literature
18.	ALA651026	ADME	Tested on CA-755 mammary adenocarcinoma and number of drug related deaths/total animals in treatment group was determined at 150 mg/kg dosage administered for 10 days intraperitoneally; 3/10	Mus musculus	1	ALA1124898	organism-based format	Scientific Literature
19.	ALA651027	Functional	Antitumor activity in vivo expressed as percent of inhibition in CA-755-mammary adenocarcinoma tumor cell line	Mus musculus	2	ALA1124898	organism-based format	Scientific Literature
20.	ALA651753	Functional	Antitumor activity in vivo expressed as percent of inhibition in C3H-mammary adenocarcinoma cell line	Mus musculus	2	ALA1124898	organism-based format	Scientific Literature